Alpha 2.0
Login Register
» Articles » PMID: 12625332

Verification of the Selectivity of (+)N-3-benzylnirvanol As a CYP2C19 Inhibitor

Overview
Journal Drug Metab Dispos
Specialty Pharmacology
Date 2003 Mar 11
PMID 12625332
Citations 7
Authors
Robert L Walsky
R Scott Obach
Affiliations
Soon will be listed here.
Citing Articles

Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates: Findings From In Vitro Analyses and an Open-Label, Single-Sequence Phase I Study.

Desch M, Schlecker C, Hohl K, Liesenfeld K, Chan T, Muller F J Clin Psychopharmacol. 2023; 43(2):113-121.

PMID: 36700734 PMC: 9988221. DOI: 10.1097/JCP.0000000000001656.

Probing functional interactions between cytochromes P450 with principal component analysis of substrate saturation profiles and targeted proteomics.

Dangi B, Davydova N, Maldonado M, Ahire D, Prasad B, Davydov D Arch Biochem Biophys. 2021; 708:108937.

PMID: 34058150 PMC: 8260145. DOI: 10.1016/j.abb.2021.108937.

Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.

Dangi B, Davydova N, Vavilov N, Zgoda V, Davydov D Xenobiotica. 2020; 50(12):1393-1405.

PMID: 32662751 PMC: 7740640. DOI: 10.1080/00498254.2020.1775913.

In vitro inhibitory effects of scutellarin on six human/rat cytochrome P450 enzymes and P-glycoprotein.

Han Y, Li D, Yang Q, Zhou Z, Liu L, Li B Molecules. 2014; 19(5):5748-60.

PMID: 24802986 PMC: 6271944. DOI: 10.3390/molecules19055748.

Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.

Burnett B, Pillai L, Bitto A, Squadrito F, Levy R Int J Womens Health. 2011; 3:139-50.

PMID: 21792336 PMC: 3140810. DOI: 10.2147/IJWH.S19309.